Reliable Brokers
Online Investing
Alerts & Analysis
Easy Trading

New drug testing lab likely to open without proper preparation

Update : 16 Dec 2013, 07:00 PM

The newly-installed high-tech drug testing National Control Laboratory (NCL) is likely to start operations on January 1, after a few months of test service.

With a Tk25 crore cost, the NCL has been set up with the financial support of World Bank and the World Health Organization on the premises of the Institute of Public Health in Mohakhali.

Selim Barami, director at the Directorate General of Drug Administration (DGDA) and also the director (in-charge) of the NCL, confirmed the date and told the Dhaka Tribune: “The NCL is fully ready to start its activities. We will start our operation from January 1, 2014, whether it is formally opened or not.”

Saying the installation of the laboratory had been completed a year ago, he added that the NCL faced a delay in going into operation because of a fire accident which destroyed some equipment and cables, while additional fund was not available at the time from the government for repair and replacement.

However, seeking anonymity, a senior official said the NCL was still not ready to run its activities smoothly. Although the laboratory was fully-equipped with modern machines and other testing facilities, there was still a shortage of well-trained expert manpower behind the machines, the official added.

Moreover, the NCL did not have its own financial budget to administer the laboratory activities as per demand, the official informed.

Currently, the NCL has been running under the Institute of Public Health, which is providing the cost of day-to-day expenses and also supplying chemicals and other materials.

It has been learnt that the newly installed lab is likely to test up to 10,000 medicine samples a year, compared to the existing laboratory’s capacity of testing only 3,000 medicine samples – an amount which was inadequate given the current size of the pharmaceuticals market.

The testing fees for existing and new medicines have been increased to Tk5,000 and Tk15,000 respectively, compared to previous fees of Tk1,500 and Tk7,500.

The NCL would also be able to test vaccines, a feature which was not previously offered in the country. The DGDA and top pharmaceuticals had to send vaccine samples to Singapore or Thailand for testing earlier, but the NCL would now offer the same services at one fifth of the expense.

Although the current state-owned lab lacked international standard, the newly-installed one is aiming to get WHO accreditation within a year, as inspection teams will visit and assess the NCL’s performance in different phases.  

Top Brokers